T4 RNA Ligase 1(10U/ul)
Cat. No. T41-E5143
| Molecule | Cat. No. | Product Name | Espèce | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| T4 RNA Ligase 1 | T4 RNA Ligase 1(10U/ul) | Escherichia phage T4 | E. coli | SDS-PAGE | $68.00 1000U |
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Plus ancien nom de marque | Pays d'approbation le plus ancien | Indication la plus ancienne | Société d'approbation la plus ancienne | Date d'approbation la plus ancienne | Indication | Essai clinique |
|---|---|---|---|---|---|---|---|---|---|---|
| Itolizumab | T-1-hT; EQ-001; T-1-h; h-T1; Bmab-600 | Approved | Biocon Ltd, Center Of Molecular Immunology, Biotech Pharmaceuticals Co Ltd | Alzumab | India | Plaque psoriasis | Biocon Ltd | 2013-01-01 | Dermatomyositis; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Coronavirus Disease 2019 (COVID-19); Lupus Nephritis; Respiratory Distress Syndrome, Adult; Psoriasis; Asthma; Plaque psoriasis | Details |